Please use this identifier to cite or link to this item:
http://hdl.handle.net/11718/23344
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | D'Souza, Errol | - |
dc.date.accessioned | 2020-12-12T14:10:43Z | - |
dc.date.available | 2020-12-12T14:10:43Z | - |
dc.date.issued | 2020-12-10 | - |
dc.identifier.uri | http://hdl.handle.net/11718/23344 | - |
dc.description | BUSINESS LINE 09/12/2020 P.05 PRESSREADER | en_US |
dc.publisher | Business Line | en_US |
dc.subject | Vaccination | en_US |
dc.subject | BioNTech-Pfizer vaccine | en_US |
dc.subject | COVID-19 | en_US |
dc.title | Why vaccination is only a part-solution | en_US |
dc.type | Newspaper | en_US |
Appears in Collections: | IIMA In Media |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
B-LINE_07_DECEMBER_2020_PRESS READER-1.jpg | B-LINE_07_DECEMBER_2020_PRESS READER-1 | 2.28 MB | JPEG | View/Open |
Items in IIMA Institutional Repository are protected by copyright, with all rights reserved, unless otherwise indicated.